4893 items matching your search terms.

1. What have we learnt from efforts to use surrogates in trials: LDL cholesterol and C-reactive protein. 2. How to make decisions about when to invest in large outcome trials

Simes, J.

Applying trial results to individual patients

Simes, J.

1. Individualising treatment decisions from clinical trial evidence. Cardiology Forum. 2. Surrogate outcomes in clinical trials. 3. Lessons from recently completed Australian Cancer Trials.

Simes, J.

Statistics in Clinical Trials

Simes, J.

Constructing decision trees

Simes, J.

Prospective registration of all trials: minimizing bias in systematic reviews

Simes, J.

Setting the future research agenda (panel discussion)

Simes, J.

Effective clinical trial design symposium

Simes, J.

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: The LIPID trial follow-up

Simes, J. Simes, R. J. Hunt, D. Kirby, A. Tonkin, A. Keech, A. Aylward, P. Colquhoun, D. Glasziou, P. Hague, W. MacMahon, S. Thompson, P. West, M. White, H.
LANCET, 2002     DOI:10.1016/S0140-6736(02)08351-4

International differences in patients, care, and outcomes associated with acute myocardial infarction: the HERO-2 trial. The HERO-2 Investigators

Simes, J.; White, H. D.; Marschner, I. C.; Varshavsky, S.; Diaz, R.; Wilcox, R. G.; Armstrong, P. W.; Granger, C. B.; French, J. K.; Van de Werf, F.; Aylward, P. E.

International differences in patients, care, and outcomes associated with acute myocardial infarction: the HERO-2 trial

Simes, J; White, HD; Marschner, IC; Varshavsky, S; Diaz, R; Wilcox, RG; Armstrong, PW; Granger, CB; French, JK; Van de Werf, F; Aylward, PE

Effects of pravastatin in the elderly [letter]

Simes, J; Young, P; Hunt, D

Clinical trials and ‘real-world’ medicine [editorial]

Simes, RJ

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

Simes, RJ Marschner, IC Hunt, D Colquhoun, D Sullivan, D Stewart, RA Hague, W Keech, A Thompson, P White, H Shaw, J Tonkin, A on behalf of the LIPID Study Investigators,

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels: the Prospective Pravastatin Pooling project

Simes, RJ; Furberg, CD; Braunwald, E; Davis, BR; Ford, I; Tonkin, A; Shepherd, J; for the Prospective Pravastatin Pooling project